Active in the International Society for Pharmacoepidemiology
and the Drug Information Association, she was appointed in 2004 as the first Industry Representative to the FDA Drug Safety and Risk Management Advisory Committee.
9 London School of Hygiene and Tropical Medicine Description of a short postgraduate course on pharmacoepidemiology
and pharmacovigilance Stephen Evans and Ann Arscott
van Staa, also of the department of pharmacoepidemiology
and pharmacotherapy, University of Utrecht (the Netherlands).
The event will attract directors and managers of clinical trials, clinical research, post-marketing, surveillance, medical affairs, pharmacoepidemiology
, investigator sponsored studies, clinical data management, drug development, pharmacovigilance, risk management from the pharmaceutical and biotechnology industries.
Solomon, director of health services research in the division of pharmacoepidemiology
and pharmacoeconomics at Brigham and Women's Hospital, Boston.
Providing drug safety and pharmacoepidemiology
expertise to assist agency in fulfilling PDUFA IV commitment
Doyle is on faculty in the Departments Epidemiology and Healthcare Policy & Management at Columbia University's Mailman School of Public Health, where he teaches courses in pharmacoepidemiology
and Drug Safety , pulled data from the weeklong online medication diary entries of more than 1,300 people to learn just how many went over the limit.
Results were published in Pharmacoepidemiology
and Drug Safety.
Healthcare company Janssen Pharmaceutical Companies onTuesday updated and published the positive findings from the US Food and Drug Administration (FDA) Mini-Sentinel pilot project assessment of XARELTO (rivaroxaban) under the phase III ROCKET AF clinical trials in Pharmacoepidemiology
& Drug Safety.
Food and Drug Administrations (FDA) Mini-Sentinel assessment, confirming the positive safety and efficacy profile of XARELTO (rivaroxaban) established in the phase III ROCKET AF clinical trials, were published in Pharmacoepidemiology
& Drug Safety.
Study author Elisabetta Patorno from BWH Division of Pharmacoepidemiology
& Pharmacoeconomics said the results suggest that the increased risk of oral clefts is most pronounced in women taking higher doses of Topiramate to treat epilepsy.